Blog

Discover our latest articles and blogs

Avoid Compounded Risk: Semaglutide Cash Costs and the Medicare Bridge
September 25, 2026

Avoid Compounded Risk: Semaglutide Cash Costs and the Medicare Bridge

Compare U.S. semaglutide cash prices—$1,000–$1,400 brand-name vs $78–$349 compounded—and get clinician-backed safety steps to lower costs plus Medicare...

LDL Falls 5 mg/dL on TRT: Evidence-Based Monitoring for Clinicians
September 24, 2026

LDL Falls 5 mg/dL on TRT: Evidence-Based Monitoring for Clinicians

Summarizes TRAVERSE, meta-analyses, FDA and guideline guidance and provides a practical lipid-monitoring workflow for clinicians and informed patients...

Cut GLP-1 Nausea by a Third with Prescriber Scripts for Patients
September 23, 2026

Cut GLP-1 Nausea by a Third with Prescriber Scripts for Patients

Clinician-informed checklist for people on GLP-1: small meals, hydration and constipation tips, plus exact scripts to ask your prescriber to slow titration.

Bioidentical vs Synthetic Hormones: 5 Questions to Ask Your Prescriber
September 22, 2026

Bioidentical vs Synthetic Hormones: 5 Questions to Ask Your Prescriber

Evidence first guide to spot FDA approved bioidentical drugs versus compounded versions. Five questions to ask your prescriber and when to choose...

Preserve Fertility on TRT: Evidence Backed hCG 250–500 IU for Men
September 21, 2026

Preserve Fertility on TRT: Evidence Backed hCG 250–500 IU for Men

Evidence backed hCG strategies to preserve fertility on TRT. Learn prevention vs recovery dosing (250–500 IU vs 1,500–3,000 IU), lab checks, and clinician...

24% Report Constipation on Semaglutide: Relief Steps for Patients
September 20, 2026

24% Report Constipation on Semaglutide: Relief Steps for Patients

Practical, clinician-backed steps to relieve semaglutide constipation, why it happens (24% in trials), how to prevent it, and when to seek urgent care.

FDA Flags 2 Dozen+ Peptides: Research Peptide Risks and Safer Care
September 19, 2026

FDA Flags 2 Dozen+ Peptides: Research Peptide Risks and Safer Care

FDA flagged 2 dozen+ research peptides. Learn the health and contamination risks, emergency red flags, and safer physician supervision options.

Two Thirds Back in 1 Year? Semaglutide Weight Regain for Clinicians
September 18, 2026

Two Thirds Back in 1 Year? Semaglutide Weight Regain for Clinicians

Learn how semaglutide weight regain typically unfolds — about 0.4 kg per month and two thirds of lost weight in year one — and clinician led tapering and...

GLP-1 Diarrhea: Immediate Steps, Red Flags, and Doctor Options
September 17, 2026

GLP-1 Diarrhea: Immediate Steps, Red Flags, and Doctor Options

Practical steps for GLP-1 diarrhea: hydration, diet, safe OTCs, and when to call your prescriber. Clinician options and supervised support available.